We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
HCA Healthcare
HCA
$84.8B
| – | – |
-57,134
| Closed | -$4.19M |
|
852
Helen of Troy
HELE
$663M
| – | – |
-7,864
| Closed | -$512K |
|
853
Huntington Ingalls Industries
HII
$11.3B
| – | – |
-65,573
| Closed | -$7.38M |
|
|
HIMX
854
Himax Technologies
HIMX
$2.2B
| – | – |
-15,129
| Closed | -$122K |
|
855
Harley-Davidson
HOG
$2.68B
| – | – |
-7,269
| Closed | -$479K |
|
856
Healthcare Realty
HR
$7.42B
| – | – |
-13,800
| Closed | -$372K |
|
857
Hancock Whitney
HWC
$6.13B
| – | – |
-33,084
| Closed | -$1.02M |
|
858
IBM
IBM
$202B
| – | – |
-22,449
| Closed | -$3.44M |
|
859
Ingredion
INGR
$6.38B
| – | – |
-9,100
| Closed | -$772K |
|
860
International Paper
IP
$22.3B
| – | – |
-5,315
| Closed | -$270K |
|
861
Itaú Unibanco
ITUB
$91.3B
| – | – |
-1,005,670
| Closed | -$5.25M |
|
862
Jack in the Box
JACK
$278M
| – | – |
-14,740
| Closed | -$1.18M |
|
863
Jazz Pharmaceuticals
JAZZ
$15.9B
| – | – |
-13,032
| Closed | -$2.13M |
|
864
JetBlue
JBLU
$1.96B
| – | – |
-156,717
| Closed | -$2.49M |
|
865
St. Joe Company
JOE
$3.57B
| – | – |
-31,303
| Closed | -$576K |
|
866
James River Group Holdings
JRVR
$218M
| – | – |
-163,000
| Closed | -$3.71M |
|
867
Kaiser Aluminum
KALU
$2.67B
| – | – |
-90,493
| Closed | -$6.46M |
|
868
KBR
KBR
$4.68B
| – | – |
-348,475
| Closed | -$5.91M |
|
869
Knowles
KN
$3.22B
| – | – |
-29,275
| Closed | -$689K |
|
870
Kroger
KR
$34.8B
| – | – |
-23,808
| Closed | -$764K |
|
871
Leidos
LDOS
$14.1B
| – | – |
-153,269
| Closed | -$6.67M |
|
872
Ligand Pharmaceuticals
LGND
$6.02B
| – | – |
-152,490
| Closed | -$5.06M |
|
873
Lennox International
LII
$18.8B
| – | – |
-191,662
| Closed | -$18.2M |
|
874
Eli Lilly
LLY
$1.07T
| – | – |
-245,452
| Closed | -$16.9M |
|
875
Grand Canyon Education
LOPE
$3.71B
| – | – |
-178,839
| Closed | -$8.35M |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.